• S&P 500: 1,342.64
  • Change: -0.69%
$3.26 0.01 (+0.46%)
2/10/2012 3:59 PM

Acura Pharmaceuticals Inc. (NASDAQ:ACUR)

CAPS Rating: 2 out of 5

A pharmaceutical company engaged in research, development and manufacture of innovative Aversion(r) Technology and related product candidates.

Current Price $3.26 Mkt Cap $147.50M
Open $3.25 P/E Ratio 21.50
Prev. Close $3.24 Div. (Yield) N/A (N/A)
Daily Range $3.25 - $3.38 Volume 63,888
52-Wk Range $2.28 - $6.80 Avg. Daily Vol. 0

News & Discussion Boards

Caps

How do you think ACUR will perform against the market?

You must Sign in to MSN Caps before you can make a call.

All Players

56 Outperform
30 Underperform
 

All-Star Players

9 Outperform
10 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top ACUR Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

davidr825 (< 20)
Submitted June 13, 2008

Unique delivery of controlled substances will make this a winner - especially when coupled with King Pharmaceutical

1 Comment | Reply | Report this Post

tcampbellla (< 20)
Submitted October 29, 2007

No thanks.

4 Comments | Reply | Report this Post
ACUR VS S&P 500 (SPY)

Recent Community Commentary

Read the most recent pitches from players about ACUR.

Recs

0
Member Avatar Lcrazylegs84 (25.63) Submitted: 10/1/2011 1:06:09 AM : Outperform Start Price: $3.50 ACUR Score: -25.59

going up

Report this Post Add Comment | Reply | Permalink

Recs

0
Member Avatar thebigpicture37 (< 20) Submitted: 6/22/2011 11:47:13 AM : Outperform Start Price: $3.97 ACUR Score: -20.99

The 20 million royalty will be paid to Acura Pharma in late June or early July. Also Pfizer plans to partner with Acura on other opioid drugs using the Aversion TM technology. However my favorite is an OTC product with pseudoephedrine which will be rolled out later this year. Nexafed TM using Impede TM technology. This drug will have the same ingredients as Sudafed TM and brand name.

Report this Post Add Comment | Reply | Permalink

Recs

0
Member Avatar KimLanners (< 20) Submitted: 6/20/2011 10:53:32 AM : Outperform Start Price: $4.98 ACUR Score: -39.46

fda approval

Report this Post Add Comment | Reply | Permalink
View All 8 Pitches »

Leaderboard

Find the members with the highest scoring picks in ACUR.

Score Leader

zzlangerhans

zzlangerhans (99.30) Score: +126.79

Persistence pays off once again.

Top
Pick 		Member Name Member
Rating 		Start
Date 		Call Time
Frame 		Start
Price 		Stock
Gain 		Index
Gain 		Score Commentary
kansalainen < 20 12/1/2008 Underperform 5Y $8.00 -59.00% +57.43% +116.43 0 Comment
mrstlouis 60.95 4/7/2009 Underperform 3M $6.35 -48.35% +64.86% +113.20 0 Comment
SmallCapsInvstr 98.10 4/28/2009 Underperform 1Y $6.46 -49.23% +59.58% +108.81 0 Comment
yunak < 20 6/24/2009 Underperform 5Y $5.77 -43.15% +49.56% +92.71 0 Comment
Nivaos < 20 8/17/2009 Underperform 1Y $5.51 -40.47% +36.41% +76.89 0 Comment
MoeLarryShemp 63.47 10/16/2007 Underperform 3Y $20.00 -83.60% -8.66% +74.94 0 Comment
tcampbellla < 20 10/29/2007 Underperform 5Y $19.30 -83.01% -8.79% +74.21 5 Comments
dow13000 < 20 10/3/2007 Underperform 5Y $18.40 -82.17% -8.42% +73.75 0 Comment
SissorsC 48.09 10/26/2007 Underperform 3W $18.10 -81.88% -8.14% +73.74 0 Comment
ActiveJunkie 99.39 10/17/2007 Underperform NS $18.75 -82.51% -9.28% +73.23 0 Comment
View Complete Scorecard »

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for ACUR.

Featured Broker Partners